|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-12-24
|
|
pubmed:abstractText |
Selective cyclooxygenase-2 (COX-2) inhibition reduces the growth of many cancer cell lines, and this effect may be mediated through induction of apoptosis. This study was designed to investigate the effects of the COX-2 inhibitor nimesulide on the growth of human pancreatic cancer cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/nimesulide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1536-4828
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
33-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12499915-Antineoplastic Agents,
pubmed-meshheading:12499915-Apoptosis,
pubmed-meshheading:12499915-Caspase 3,
pubmed-meshheading:12499915-Caspases,
pubmed-meshheading:12499915-Cell Division,
pubmed-meshheading:12499915-Cell Survival,
pubmed-meshheading:12499915-Cyclooxygenase 2,
pubmed-meshheading:12499915-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:12499915-Cyclooxygenase Inhibitors,
pubmed-meshheading:12499915-Humans,
pubmed-meshheading:12499915-Isoenzymes,
pubmed-meshheading:12499915-Membrane Proteins,
pubmed-meshheading:12499915-Pancreatic Neoplasms,
pubmed-meshheading:12499915-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:12499915-RNA, Messenger,
pubmed-meshheading:12499915-Sulfonamides,
pubmed-meshheading:12499915-Tumor Cells, Cultured
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.
|
|
pubmed:affiliation |
Division of General Surgery, David Geffen School of Medicine, University of California at Los Angeles, California CA 90095-6904, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
